QR code

Prostate- and metastases-directed radiotherapy in de novo low-volume metastatic prostate cancer

Background: The role of radiotherapy in de novo low-volume metastatic prostate cancer (LVmPC) is constantly evolving and still offers considerable potential for further optimization. Rising interest in this topic demands further investigations in this specific patient cohort. We report on clinical o...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Jan-Hendrik Bolten, Fabian Weykamp, Christoph Grott, David Neugebauer, Lars Wessel, Felix H. Englert, Justus Valentini, Magdalena Goertz, Stephanie Zschaebitz, Johannes Huber, Erik Winter, Juergen Debus, Jakob Liermann
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2026-01-01
Reeks:Clinical and Translational Radiation Oncology
Onderwerpen:
Excellent tolerability of ablative radiotherapy of all PSMA-PET positive tumor manifestations in low-volume disease of oligometastatic prostate cancer
Importance of PSMA-PET-Staging in oligometastatic prostate cancer
Further stratification in low volume disease of oligometastatic prostate cancer is needed
Online toegang:http://www.sciencedirect.com/science/article/pii/S2405630825001648
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items